Featured Insights

1. How To Effectively Manage Local Affiliate Pharmacovigilance Outsourcing 5/12/2026

   Managing PV across dozens of markets strains even experienced safety teams. Learn about a framework that helps you maintain compliance, reduce risk, and scale confidently into new markets.

2. Mid-Sized Pharma Optimizes Local Affiliate Safety Operations 5/12/2026

   Managing local affiliate PV strains any team. See how a mid-sized biopharma standardized ICSR processing across 94 countries, improved compliance tracking, and achieved centralized oversight.

3. How Automation Increases Efficiency And Accuracy Of Local PV Monitoring And KPI Tracking 5/12/2026

   Local pharmacovigilance monitoring is straining safety teams with manual overhead and growing regulatory complexity. Learn how automation improves KPI tracking, SLA compliance, and multi-country affiliate oversight while reducing costs.

4. When CGT Supply Chains Break Down: 5 Operational Gaps That Put Patient Outcomes At Risk 4/22/2026

   Examine five of the most consequential gaps in CGT supply chain performance and learn what high-functioning teams do differently to protect patient outcomes before a failure occurs.

5. Addressing A Critical Drug Shortage 4/20/2026

   A critical drug shortage demanded regulatory action, importation support, and patient program readiness. See how integrated QA, 3PL, and PSP capabilities delivered operational readiness in three months.

6. Foreign Action Notification To Health Canada 4/20/2026

   Health Canada is tightening foreign action reporting expectations. MAHs need to understand what the updated draft guidance means for their compliance and monitoring processes now.

7. Best Practices For Managing The Logistics And Distribution Of CGTs 2/23/2026

   Site infrastructure, formulary timelines, and storage capabilities create barriers between approval and patient access. Planning for these operational realities separates successful launches from stalled ones.

8. Navigating EU Regulatory Challenges With Cell And Gene Therapies 2/23/2026

   EU regulatory changes affecting advanced therapies demand new approaches to scientific advice, evidence generation, and health technology assessment for cell and gene therapy developers.

9. Transforming PSP Enrollment To Enhance User Experiences And Optimize Workflows 2/18/2026

   Lengthy enrollment calls burden patients and PSP teams alike. See how a digital-first intake approach cut onboarding time and improved outcomes for everyone involved.

10. The Value Of Real-World Evidence In Canadian Drug Commercialization 2/18/2026

    Leveraging real-world evidence (RWE) across the product lifecycle enables manufacturers to fill the evidence gap beyond RCTs to help guide local commercial strategic planning and market access strategy.